Bernstein launches coverage of Canada’s Tilray, Cronos and Canopy Growth but stops short of any buy ratings

Sanford C. Bernstein & Co. analyst Nadine Sarwat initiated coverage of three Canadian cannabis stocks on Wednesday but stopped short of any buy recommendations at current levels. “Is the buzz gone...

These cannabis stocks could benefit from adult-use cannabis legalization in Germany

While it’s too early to predict winners and losers among U.S. and Canadian cannabis companies, some of these players are expected to see a boost in sales as Germany moves toward nationwide legalizatio...

Canopy Growth Stock Is Falling as Earnings Disappoint Wall Street

Text size Canopy Growth reported a 36% drop in revenue from Canadian recreational cannabis sales compared with the same quarter a year ago. Chris Roussakis/Bloomberg Canopy Growth stock is plummeting ...